MENU
ELTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Elicio Therapeutics (ELTX) Ownership - Who owns Elicio Therapeutics?
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes... Show more
Profile
Industry
N/A
Address
451 D Street
Phone
+1 857 209-0050
Employees
32
Web
https://www.elicio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
80.57M
P/E Ratio
5.96
Total Cash
26.02M
Projected Growth
N/A
Total Debt
26.05M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
1.63
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ELTX
Capitalization
80.6M
P/E Ratio
5.96
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
26M
Total Cash/Share
1.63
Total Debt
26M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-18.99M
P/B Ratio
10.02
Cash Flow
N/A
Earnings
-3.44
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
108K
Current Ratio
3.40
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-45.46M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-135.04
Shares Held By Institutions
4.67M
Shares Outstanding - Current
16M
Total Liabilities
57.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
1.471
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
451 D Street
Phone
+1 857 209-0050
Employees
32
Web
https://www.elicio.com